{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-024149","form_type":"8-K","ticker":"ZVIA","cik":"0001854139","company_name":"Zevia PBC","filed_at":"2022-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.768315+00:00","generated_at":"2026-06-21T23:56:12.625667+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Zevia Q3 Net Sales $44.2M (+13.6% YoY); Net Loss $9.2M; Resets FY2022 Revenue Guidance to $158-160M","bullets":["Net sales $44.2M, up 13.6% YoY; unit volume +2.3% to 3.6M cases.","Gross margin 43.3%, up 90bp sequentially; net loss $9.2M ($0.17 EPS loss), improved from $49.8M loss YoY.","Adjusted EBITDA loss improved to $2.1M from $3.5M YoY; cash $49.2M, no debt.","FY2022 net sales guidance reduced to $158-160M (14.2-15.7% growth); Q4 outlook $30-32M.","Cites customer inventory pressures and macro environment as headwinds."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-024149","json":"https://secwatch.observer/filing/0000950170-22-024149.json","markdown":"https://secwatch.observer/filing/0000950170-22-024149.md","text":"https://secwatch.observer/filing/0000950170-22-024149.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1854139/000095017022024149/0000950170-22-024149-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1854139/000095017022024149/zvia-20221110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T23:56:12.625667+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1bcfad048ba3b972285f0be1c467f6c1a02df4ab","claim":"Zevia PBC reported third quarter ended September 30, 2022 results: revenue $44.2 million, net income $9.2 million, EPS $0.17 per diluted share. Guidance reaffirmed.","evidence_excerpt":"plant-based ingredients, today reported results for the third quarter ended September 30, 2022. Third Quarter 2022 Highlights • Net sales increased 13.6% year over year to $44.2 million • Unit volume increased 2.3% year over year to 3.6 million equivalized cases • Gross profit margin of 43.3% (1) • Net loss was $9.2 million, including $6.8 million of non-cash","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1854139/000095017022024149/0000950170-22-024149-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Revenue","value":"$44.2 million"},{"label":"Net income","value":"$9.2 million"},{"label":"EPS","value":"$0.17 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}